Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
OneCell Diagnostics Inc. | $16,000,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Certified by Founder
Lodge
Nephron Pharmaceuticals
start up
United States
- West Columbia, South Carolina
- 18/09/2023
- Unknown
- $350,000,000
Nephron Pharmaceuticals Corporation is a mid-sized company that manufactures generic respiratory medications. NPC sells to many classes of trade, including, but not limited to, hospitals, pharmacies, long term care facilities, home care companies and mail order pharmacies. These medications are used in the treatment of asthma and COPD.
- Industry Pharmaceutical Manufacturing
- Website https://www.nephronpharm.com/
- LinkedIn https://www.linkedin.com/company/nephron-pharm/about/
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
CredFlow | $3,700,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)